The mean duration of illness in families with PS-1 mutations is
 significantly shorter (range 5.8-6.8 years) than in families with both PS-2
 (range 4.4-10.8 years) and APP mutations (range 9.0-16 years), reflecting the
 severity of PS-1-associated Alzheimer's disease.
